EUVIMED · CrossrefJournal
European Heart Journal - Quality of Care and Clinical Outcomes
ISSN 2058-5225 · Oxford University Press (OUP)
Latest articles
Cardiac rehabilitation accreditation needs a shared European registry
Life’s Essential 10 and healthspan: implications for cardiovascular prevention
Mapping Cardiovascular Prediction Models in the General Population: Where Are We Now and Where Next?
Cardiovascular Morbidity and Functional Dependency in an Ageing Europe: EU27 Projections to 2050
Projected One-Year Benefit of Heart Failure Pharmacotherapy in Adults With a Fontan Circulation
Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry
Anti-obesity medications in adults with congenital heart disease: a comprehensive review and expert clinical recommendations
Heart failure guideline-directed medical therapy in young adults with dystrophin-related cardiomyopathy: the HOPE-MD registry
Strengthening the pre-hospital chain of survival for out-of-hospital cardiac arrest
Cardiac rehabilitation programme accreditation and certification: Comparing international practices, mapping standards, benchmarks, and future directions – A scoping review
Deterministic economic modelling study of tafamidis in transthyretin amyloid cardiomyopathy across four European healthcare systems
Socioeconomic deprivation and post-discharge mortality in heart failure: evidence from a nationwide universal health coverage system
Integrating cardiac biomarkers into the AHA PREVENT equations: impact on atherosclerotic cardiovascular disease risk stratification
Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations
Integrating genetic and imaging information to enhance cardiovascular risk stratification: rationale and design of the CVRISK-IT randomized controlled trial
Method validation of cardiopulmonary exercise testing: intra- and inter-device comparisons across four metabolic carts
From paper charts to precision prevention: why cardiovascular risk estimation must move online
Shifting paradigms in ICD tachytherapy deactivation in the final phase of life: eighteen years of perspective
Missed opportunity for fibrinolysis in ST-segment–elevation myocardial infarction: the nationwide France-PCI registry
Interaction between GRASP-HF and ICARe-HF: a strategic alliance to improve heart failure care in Europe and beyond
Evaluating TAVI quality indicators: critical insights from the SWEDEHEART experience and future directions
Pharmacological treatment after a first myocardial infarction in Sweden—long-term adherence and prognosis
Association of GLP-1 receptor agonists versus bariatric surgery with outcomes in obese patients with hypertrophic cardiomyopathy: a multicenter propensity-matched analysis
Mind the missed-fibrinolysis gap
Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm
Between evidence and ambiguity: reassessing HFrEF guidelines
End-of-life management in patients with implantable cardioverter-defibrillators: a core responsibility throughout the cardiology pathway
Atrial fibrillation and risk of myocardial infarction in women and men: similar, yet so different
Bridging the cardio-psychiatric divide in the era of COVID-19: a critical appraisal of post-MI outcomes in patients with mental disorders
Heart failure, inequality, and the decades before admission
EUVIMED